Clinical Trials Browser

Phase 1 × NHS-IL12 immunocytokine × Clear all

NCT04756505 2023-12-27

Immunotherapy (NHS-IL12 & Bintrafusp Alfa) and Radiation Therapy for the Treatment of Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer, the REINA Trial

Phase 1 Withdrawn

Breast Neoplasms

NCT01417546 2021-10-18

NHS-IL12 for Solid Tumors

Phase 1 Completed

Malignant mesenchymal tumor, Carcinoma